X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/biontech-pays-autolus-250m-manufacturing-car-t-expertise-wide-ranging-collab
https://endpts.com/autolus-eyes-november-for-potential-us-approval-of-tecartus-rival/
https://endpts.com/biotech-car-t-roundup-autolus-gracell-tout-early-stage-data-at-ash/
https://www.fiercebiotech.com/biotech/autolus-outlines-path-fda-after-car-t-cell-therapy-trial-hits-primary-endpoint
https://endpts.com/autolus-tips-its-hand-bags-220m-as-car-t-showdown-with-gilead-looms/
https://www.barrons.com/articles/autolus-therapeutics-to-present-three-clinical-data-updates-at-the-american-society-of-hematology-ash-annual-meeting-2022-01667482573
https://www.fiercebiotech.com/biotech/moderna-says-yes-autolus-licensing-targeting-technology-immuno-oncology-project
https://www.fiercebiotech.com/biotech/bms-wants-lightbulb-moment-pens-deal-access-autoluss-cell-therapy-switch
https://www.globenewswire.com/news-release/2022/10/04/2527627/0/en/Autolus-Therapeutics-Announces-Collaboration-with-Bristol-Myers-Squibb-for-Use-of-Autolus-Proprietary-Safety-Switch-System.html#:~:text=The%20agreement%20grants%20Bristol%20Myers,switch%20in%20additional%20cell%20therapy
https://www.globenewswire.com/news-release/2022/05/12/2442194/0/en/Autolus-Therapeutics-to-Present-Four-Clinical-Data-Updates-at-the-European-Hematology-Association-Congress.html
Market Place
Share 
